Net profit of Metropolis Healthcare rose 13.22% to Rs 52.67 crore in the quarter ended September 2025 as against Rs 46.52 crore during the previous quarter ended September 2024. Sales rose 22.70% to Rs 429.19 crore in the quarter ended September 2025 as against Rs 349.79 crore during the previous quarter ended September 2024. ParticularsQuarter EndedSep. 2025Sep. 2024% Var. Sales429.19349.79 23 OPM %25.2225.70 - PBDT103.4388.21 17 PBT71.0361.40 16 NP52.6746.52 13 Powered by Capital Market - Live News

Metropolis Healthcare announced that the Board of Directors of the Company at its meeting held on 4 November 2025, inter alia, have recommended the interim dividend of Rs 4 per equity Share (i.e. 200%) , subject to the approval of the shareholders.Powered by Capital Market - Live News

Net profit of Metropolis Healthcare rose 10.34% to Rs 46.63 crore in the quarter ended September 2025 as against Rs 42.26 crore during the previous quarter ended September 2024. Sales rose 10.62% to Rs 355.71 crore in the quarter ended September 2025 as against Rs 321.57 crore during the previous quarter ended September 2024. ParticularsQuarter EndedSep. 2025Sep. 2024% Var. Sales355.71321.57 11 OPM %25.6825.51 - PBDT89.9080.88 11 PBT62.1154.87 13 NP46.6342.26 10 Powered by Capital Market - Live News

Metropolis Healthcare will hold a meeting of the Board of Directors of the Company on 4 November 2025.Powered by Capital Market - Live News

Metropolis Healthcare has allotted 14,522 equity shares under ESOP on 12 October 2025. With this, the paid up equity share capital has increased to Rs 10,36,43,964. Powered by Capital Market - Live News